TRE-515 has received FDA fast track designation for treating PSMA-positive mCRPC, aiming to accelerate its development and availability. The drug is being tested in combination with Pluvicto, a ...
Almost all men experience enlargement of their prostate gland as they get older. Often called benign prostatic hyperplasia (BPH), the condition is not cancer and doesn’t raise the risk for cancer. An ...